ADVERTISEMENT
Advertise

Content

List volumes - List articles in this issue

Scalp Stratum Corneum Histamine Levels: Novel Sampling Method Reveals Association with Itch Resolution in Dandruff/Seborrhoeic Dermatitis Treatment

doi: 10.2340/00015555-1073

Abstract:

Dandruff and seborrhoeic dermatitis are accompanied by bothersome itch. We have established a novel non-invasive methodology to sample histamine levels in the stratum corneum in order to facilitate an understanding of pruritogenesis in this condition. Histamine levels were assessed in two groups of subjects with dandruff before and after 3 weeks of treatment with a commercial potentiated zinc pyrithione shampoo. A comparative population without dandruff was also studied. Itch self-perception was quantified on a visual analogue scale. The histamine level in subjects with dandruff was more than twice that in those who did not have dandruff. Under conditions known to resolve flaking symptoms, the shampoo led to a reduction in histamine in subjects with dandruff to a level that was statistically indistinguishable from those who did not have dandruff. This reduction in histamine was accompanied by a highly significant reduction in the perception of itch intensity. These findings suggest an association between the subjective perception of itch in the scalp and the level of histamine in the skin.

Authors:

Kathy Kerr, James R. Schwartz, Thomas Filloon, Angela Fieno, Ken Wehmeyer, Jacek C. Szepietowski, Kevin J. Mills

References

  1. Warner RR, Schwartz JR, Boissy Y, Dawson Jr. TL. Dandruff has an altered stratum corneum ultrastructure that is improved with zinc pyrithione shampoo. J Am Acad Dermatol 2001; 45: 897–903. [CrossRef]
  2. Ashbee HR, Evans EGV. Immunology of diseases associated with Malassezia species. Clin Microbiol Rev 2002; 15: 21–57. [CrossRef]
  3. Chen SC, Yeung J, Chren M. Scalpdex. A quality-of-life instrument for scalp dermatitis. Arch Dermatol 2002; 138: 803–807. [CrossRef]
  4. Akdis CA, Jutel M, Akdis M. Regulatory effects of histamine and histamine receptor expression in human allergic and immune responses. Chem Immunol Allergy 2008; 94: 67–82. [CrossRef]
  5. Zampelli E, Tiligada E. The role of histamine H4 receptor in immune and inflammatory disorders. Br J Pharmacol 2009; 157: 24–33. [CrossRef]
  6. Twycross R, Greaves MW, Handwerker H, Jones EA, Libretto SE, Szepietowski JC, et al. Itch: scratching more than the surface. Q J Med 2003; 96: 7–26. [CrossRef]
  7. Herman SM, Vender RB. Antihistamines in the treatment of dermatitis. J Cutan Med Surg 2003; 7: 467–473. [CrossRef]
  8. Reich A, Szepietowski JC. Mediators of pruritis in psoriasis. Mediators Inflamm 2007; 47: 861–863. [CrossRef]
  9. Ashida Y, Denda M. Dry environment increases mast cell number and histamine content in dermis in hairless mice. Br J Dermatol 2003; 149: 240–247. [CrossRef]
  10. Danarti R, Waskito F, Indrastuti N. Onset and duration of action of topical antihistamine: a study of histamine skin test response. Intl J Dermatol 2008; 106: 785–789. [CrossRef]
  11. Giustizieri ML, Albanesi C, Fluhr J, Gisondi P, Norgauer J, Girolomoni G. H1 histamine receptor mediates inflammatory responses in human keratinocytes. J Allergy Clin Immunol 2004; 114: 1176–1182. [CrossRef]
  12. Malaviya R, Morrison AR, Pentland AP. Histamine in human epidermal cells is induced by ultraviolet light injury. J Invest Dermatol 1996; 106: 785–789. [CrossRef]
  13. Harding CR, Moore AE, Rogers JS, Meldrum H, Scott AE, McGlone FP. Dandruff: a condition characterized by decreased levels of intercellular lipids in scalp stratum corneum and impaired barrier function. Arch Dermatol Res 2002; 294: 221–230. [CrossRef]
  14. Kerr K, Darcy T, Henry J, Mizoguchi H, Schwartz JR, Morrall S, et al. A description of epidermal changes associated with symptomatic resolution of dandruff: biomarkers of scalp health. Int J Dermatol 2011; 50: 102–113. [CrossRef]
  15. Schwartz JR. Product pharmacology and medical actives in achieving therapeutic benefits. J Invest Dermatol Symp Proc 2005; 10: 198–200. [CrossRef]
  16. Billhimer WL, Bryant PB, Murray KP, Coffindaffer TW, Rains GY, Amon RB, et al. Results of clinical trial comparing 1% pyrithione zinc and 2% ketoconazole shampoos. Cosm Derm 1996; 9: 34–39. [CrossRef]
  17. Behrendt H, Ring J. Histamine, antihistamines and atopic eczema. Clin Exp Allergy 1990; 20 Suppl 4: 25–30. [CrossRef]
  18. Petersen L, Hansen U, Kristensen JK, Nielsen H, Skov PS, Nielsen HJ. Studies on mast cells and histamine release in psoriasis: the effect of ranitidine. Acta Derm Venereol 1998; 78: 190–193. [CrossRef]
  19. Krogstad AL, Lonnroth P, Goran L, Wallin BG. Increased interstitial histamine concentration in the psoriatic plaque. J Invest Dermatol 1997; 109: 632–635. [CrossRef]
  20. Johnson BA, Nunley JR. Treatment of seborrheic dermatitis. Amer Fam Phys 2000; 61: 2703–2710. [CrossRef]
  21. Goldstein SM, Kaempfer CE, Proud D, Schwartz LB, Irani AM, Wintroub BU. Detection and partial characterization of a human mast cell carboxypeptidase. J Immunol 1987; 139: 2724–2729. [CrossRef]
  22. Gallia SJ, Maurer M, Lantz CS. Mast cells as sentinels of innate immunity. Curr Opin Immunol 1999; 11: 53–59. [CrossRef]
  23. Stander S, Steinhoff M, Schmelz M, Weisshaar E, Metze D, Luger T. Neurophysiology of pruritus. Arch Dermatol 2003; 139: 1463–1470. [CrossRef]
  24. Yosipovitch G, Greaves MW, Schmelz M. Itch. Lancet 2003; 361: 690–694. [CrossRef]
  25. Kwon YS, Oh SH, Wu WH, Bae BG, Lee HJ, Lee MG, et al. CC chemokines as potential immunologic markers correlated with clinical improvement of atopic dermatitis patients by immunotherapy. Exp Dermatol 2009; 19: 246–251. [CrossRef]

Share with your friends





Actions


Abstract

Full text

PDF

Supplementary


There is no supplementary for this article.

Print information


Volume 91, Issue 4

DOI: 10.2340/00015555-1073

Pages: 404-408

View at PubMed